Clinical Trials Directory

Trials / Unknown

UnknownNCT01597999

Benefits of Breast MRI for Predicting of Histopathologic Cell Type of Small Breast Cancer

Accuracy of Magnetic Resonance Imaging (MRI) in Predicting Aggressiveness of Early Breast Cancer According to Molecular Subtypes Identified by ER PR and HER-2 Status

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Mahidol University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study examines the additional benefits of magnetic resonance imaging (MRI) with Gadovist in early breast cancer with poor prognostic features.

Detailed description

Dedicated Contrast-enhanced Magnetic Resonance Imaging (DCE-MRI)

Conditions

Interventions

TypeNameDescription
RADIATIONMRImagnetic resonance imaging (MRI) with Gadovist in early breast cancer with poor prognostic features

Timeline

Start date
2011-02-01
Primary completion
2012-07-01
Completion
2013-12-01
First posted
2012-05-15
Last updated
2013-01-23

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01597999. Inclusion in this directory is not an endorsement.